Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient

  • Stefania Mantarro1,
  • Marco Tuccori2Email author,
  • Giuseppe Pasqualetti3,
  • Sara Tognini3,
  • Sabrina Montagnani1,
  • Fabio Monzani3 and
  • Corrado Blandizzi4
BMC Geriatrics201212:69

DOI: 10.1186/1471-2318-12-69

Received: 25 April 2012

Accepted: 17 October 2012

Published: 13 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
25 Apr 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Jul 2012 Reviewed Reviewer Report - Mario Di Napoli
23 Jul 2012 Reviewed Reviewer Report - Eugen-Bogdan Petcu
22 Aug 2012 Author responded Author comments - Marco Tuccori
Resubmission - Version 3
22 Aug 2012 Submitted Manuscript version 3
11 Sep 2012 Reviewed Reviewer Report - Eugen-Bogdan Petcu
14 Sep 2012 Reviewed Reviewer Report - Mario Di Napoli
10 Oct 2012 Author responded Author comments - Marco Tuccori
Resubmission - Version 4
10 Oct 2012 Submitted Manuscript version 4
Publishing
17 Oct 2012 Editorially accepted
13 Nov 2012 Article published 10.1186/1471-2318-12-69

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Tuscan Regional Centre for Pharmacovigilance, Interdepartmental Centre for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa
(2)
Tuscan Regional Centre for Pharmacovigilance, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa
(3)
Geriatric Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa
(4)
Tuscan Regional Centre for Pharmacovigilance Division of Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa

Advertisement